MRPL28
geneOn this page
Also known as p15bL28m
Summary
MRPL28 (mitochondrial ribosomal protein L28, HGNC:14484) is a protein-coding gene on chromosome 16p13.3, encoding Large ribosomal subunit protein bL28m (Q13084). It is a selective cancer dependency (DepMap: 51.5% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein, a part of which was originally isolated by its ability to recognize tyrosinase in an HLA-A24-restricted fashion.
Source: NCBI Gene 10573 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 68 total
- Cancer dependency (DepMap): dependent in 51.5% of screened cell lines
- MANE Select transcript:
NM_006428
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14484 |
| Approved symbol | MRPL28 |
| Name | mitochondrial ribosomal protein L28 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | p15, bL28m |
| Ensembl gene | ENSG00000086504 |
| Ensembl biotype | protein_coding |
| OMIM | 604853 |
| Entrez | 10573 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 22 protein_coding, 4 retained_intron
ENST00000199706, ENST00000389675, ENST00000441883, ENST00000447696, ENST00000450882, ENST00000461550, ENST00000469744, ENST00000481453, ENST00000483764, ENST00000648346, ENST00000875015, ENST00000875016, ENST00000875017, ENST00000875018, ENST00000875019, ENST00000875020, ENST00000933144, ENST00000933145, ENST00000933146, ENST00000933147, ENST00000933148, ENST00000933149, ENST00000933150, ENST00000933151, ENST00000933152, ENST00000933153
RefSeq mRNA: 1 — MANE Select: NM_006428
NM_006428
CCDS: CCDS32349
Canonical transcript exons
ENST00000199706 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001506621 | 368501 | 368635 |
| ENSE00001506622 | 369068 | 369220 |
| ENSE00001529988 | 370499 | 370538 |
| ENSE00003622338 | 369931 | 370225 |
| ENSE00003646235 | 368328 | 368414 |
| ENSE00003831738 | 366969 | 367782 |
Expression profiles
Bgee: expression breadth ubiquitous, 286 present calls, max score 97.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 31.4721 / max 142.2393, expressed in 1819 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155726 | 27.6957 | 1819 |
| 155724 | 2.8918 | 1443 |
| 155725 | 0.8846 | 627 |
Top tissues by expression
297 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 97.51 | gold quality |
| left testis | UBERON:0004533 | 96.29 | gold quality |
| right testis | UBERON:0004534 | 96.27 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.04 | gold quality |
| putamen | UBERON:0001874 | 95.95 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.90 | gold quality |
| prefrontal cortex | UBERON:0000451 | 95.84 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 95.72 | gold quality |
| cingulate cortex | UBERON:0003027 | 95.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.37 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.30 | gold quality |
| amygdala | UBERON:0001876 | 95.16 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.08 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.04 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.91 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.73 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.73 | gold quality |
| granulocyte | CL:0000094 | 94.66 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.55 | gold quality |
| cardiac atrium | UBERON:0002081 | 94.49 | gold quality |
| testis | UBERON:0000473 | 94.45 | gold quality |
| heart | UBERON:0000948 | 94.21 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.18 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.16 | gold quality |
| muscle of leg | UBERON:0001383 | 94.09 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.05 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.99 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.89 |
| E-GEOD-106540 | no | 447.99 |
| E-MTAB-6678 | no | 3.46 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting MRPL28, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
| HSA-MIR-1247-3P | 83.69 | 63.18 | 99 |
| HSA-MIR-5587-3P | 82.90 | 60.79 | 138 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 51.5% of screened cell lines.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl28 | ENSDARG00000057805 |
| mus_musculus | Mrpl28 | ENSMUSG00000024181 |
| rattus_norvegicus | Mrpl28 | ENSRNOG00000042720 |
| drosophila_melanogaster | mRpL28 | FBGN0031660 |
| caenorhabditis_elegans | WBGENE00020796 |
Protein
Protein identifiers
Large ribosomal subunit protein bL28m — Q13084 (reviewed: Q13084)
Alternative names: 39S ribosomal protein L28, mitochondrial, Melanoma antigen p15, Melanoma-associated antigen recognized by T-lymphocytes
All UniProt accessions (4): Q13084, A2IDC6, A2IDC7, Q4TT37
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. Interacts with OXA1L.
Subcellular location. Mitochondrion.
Tissue specificity. Found in a variety of normal tissues including spleen, testes, thymus, liver, kidney, brain, adrenal, lung and retinal tissue.
Miscellaneous. Potentially represents an important therapeutic reagent for HLA-A24 patients. This antigen is recognized by tumor-infiltrating lymphocyte (TIL) 1290 in the context of HLA-A24.
Similarity. Belongs to the bacterial ribosomal protein bL28 family.
RefSeq proteins (1): NP_006419* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026569 | Ribosomal_bL28 | Family |
| IPR034704 | Ribosomal_bL28/bL31-like_sf | Homologous_superfamily |
| IPR037147 | Ribosomal_bL28_sf | Homologous_superfamily |
Pfam: PF00830
UniProt features (34 total): helix 16, strand 7, turn 3, sequence variant 3, sequence conflict 3, transit peptide 1, chain 1
Structure
Experimental structures (PDB)
86 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF0 | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | ELECTRON MICROSCOPY | 2.5 |
| 7PO4 | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 8QU1 | ELECTRON MICROSCOPY | 2.74 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q13084-F1 | 92.58 | 0.89 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 131 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, MORF_MTA1, BORCZUK_MALIGNANT_MESOTHELIOMA_UP, XU_GH1_AUTOCRINE_TARGETS_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_MITOCHONDRIAL_TRANSLATION, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, HNF1_Q6, GOBP_TRANSLATION, MORF_RAF1, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, HP1SITEFACTOR_Q6, GOCC_MITOCHONDRIAL_ENVELOPE
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (7): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial large ribosomal subunit (GO:0005762), cytosol (GO:0005829), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1318 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL28 | MRPS26 | Q9BYN8 | 536 |
| MRPL28 | TYR | P14679 | 513 |
| MRPL28 | CSF2 | P04141 | 490 |
| MRPL28 | ACP6 | Q9NPH0 | 437 |
| MRPL28 | IL2 | P01585 | 384 |
| MRPL28 | EME2 | A4GXA9 | 381 |
| MRPL28 | MRPL38 | Q96DV4 | 372 |
| MRPL28 | WDR27 | A2RRH5 | 349 |
| MRPL28 | POLR2D | O15514 | 344 |
| MRPL28 | EMC3 | Q9P0I2 | 340 |
| MRPL28 | ABHD2 | P08910 | 325 |
| MRPL28 | ARRDC4 | Q8NCT1 | 318 |
| MRPL28 | HCCS | P53701 | 317 |
| MRPL28 | MPG | P29372 | 315 |
| MRPL28 | MRPL12 | P52815 | 311 |
IntAct
212 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MRPL28 | TRAF4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TRAF4 | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.670 |
| IGF1R | PIK3R2 | psi-mi:“MI:2364”(proximity) | 0.590 |
| TRAF3IP2 | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDR2 | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | TEF | psi-mi:“MI:0915”(physical association) | 0.560 |
| HMBOX1 | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BANP | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | IKZF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | CDR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | HMBOX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM9B | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | BANP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEF | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSHZ3 | MRPL28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | LARP1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | LENG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL28 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (386): MRPL28 (Two-hybrid), MRPL28 (Two-hybrid), MRPL28 (Two-hybrid), TRAF3IP2 (Two-hybrid), IKZF3 (Two-hybrid), BANP (Two-hybrid), HMBOX1 (Two-hybrid), FAM9B (Two-hybrid), MRPL28 (Affinity Capture-MS), MRPL45 (Affinity Capture-MS), MRPL46 (Affinity Capture-MS), MRPL9 (Affinity Capture-MS), MRPL32 (Affinity Capture-MS), MRPL40 (Affinity Capture-MS), MRPL3 (Affinity Capture-MS)
ESM2 similar proteins: A0AJY7, B1VKG7, O60783, P56556, P82915, P82920, P82933, Q02366, Q0MQA3, Q0MQA4, Q0MQA5, Q0VFH6, Q13084, Q19V89, Q1JQ99, Q29IK4, Q2HJJ1, Q2TA12, Q2TBR2, Q3T040, Q3T0J3, Q498T4, Q58DQ5, Q58DV5, Q5I0K8, Q5T653, Q5U4Z8, Q5ZMU0, Q6B860, Q6DDY9, Q6P1L8, Q71YD4, Q7M0E7, Q7SF85, Q7ZUH5, Q80X85, Q8MFA1, Q8Y620, Q92AC7, Q9BYC9
Diamond homologs: A0L5U1, A1B4S6, A1UR12, A3PHM3, A4WX84, A5CC87, A5G211, A5VSY2, A6UCK6, A6WXD5, A7HTU2, A7IHE7, A8IMG3, A8LHY2, A9HS05, A9M9A0, B0CJB7, B2IEP2, B2S8R7, B3CV48, B3PPE3, B3QAG7, B4RFQ5, B5ZRX6, B6IW31, B8EQN3, B9JBS8, B9JTL3, C0RFQ6, C3MHW1, O60091, P36525, P66140, P66141, Q0AMB1, Q0BWH4, Q11DS9, Q13084, Q1GIW2, Q1GPG7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL28 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 166 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 27 | 33.2× | 8e-33 |
| Mitochondrial ribosome-associated quality control | 30 | 32.9× | 5e-36 |
| Mitochondrial translation initiation | 28 | 31.7× | 2e-33 |
| Mitochondrial translation elongation | 28 | 31.7× | 2e-33 |
| Mitochondrial translation termination | 28 | 27.4× | 1e-31 |
| Transport of Mature Transcript to Cytoplasm | 5 | 17.0× | 2e-04 |
| Translation | 29 | 16.1× | 1e-25 |
| Peptide chain elongation | 11 | 12.5× | 5e-08 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 29 | 33.8× | 4e-34 |
| translation | 28 | 19.3× | 1e-25 |
| cytoplasmic translation | 11 | 13.7× | 1e-07 |
| regulation of signal transduction by p53 class mediator | 5 | 12.8× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
906 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:367782:CCT:C | acceptor_loss | 1.0000 |
| 16:367783:C:CC | acceptor_gain | 1.0000 |
| 16:367783:CTG:C | acceptor_loss | 1.0000 |
| 16:368325:CACC:C | donor_loss | 1.0000 |
| 16:368326:A:AC | donor_gain | 1.0000 |
| 16:368326:A:C | donor_loss | 1.0000 |
| 16:368327:C:CC | donor_gain | 1.0000 |
| 16:368327:CCTT:C | donor_gain | 1.0000 |
| 16:368410:AATTC:A | acceptor_gain | 1.0000 |
| 16:368411:ATTC:A | acceptor_gain | 1.0000 |
| 16:368412:TTC:T | acceptor_gain | 1.0000 |
| 16:368413:TC:T | acceptor_gain | 1.0000 |
| 16:368414:CC:C | acceptor_gain | 1.0000 |
| 16:368415:C:CC | acceptor_gain | 1.0000 |
| 16:368415:CT:C | acceptor_loss | 1.0000 |
| 16:368420:C:CT | acceptor_gain | 1.0000 |
| 16:368421:A:T | acceptor_gain | 1.0000 |
| 16:368424:C:CT | acceptor_gain | 1.0000 |
| 16:368425:A:T | acceptor_gain | 1.0000 |
| 16:368496:CTCAC:C | donor_loss | 1.0000 |
| 16:368497:TCAC:T | donor_loss | 1.0000 |
| 16:368499:A:AC | donor_gain | 1.0000 |
| 16:368499:A:AT | donor_loss | 1.0000 |
| 16:368499:AC:A | donor_gain | 1.0000 |
| 16:368500:C:CC | donor_gain | 1.0000 |
| 16:368500:C:CT | donor_loss | 1.0000 |
| 16:368500:CC:C | donor_gain | 1.0000 |
| 16:369063:CTTG:C | donor_loss | 1.0000 |
| 16:369064:TTGC:T | donor_loss | 1.0000 |
| 16:369065:TG:T | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000412168 (16:369460 T>A), RS1001531675 (16:368877 G>A,T), RS1001585924 (16:369302 C>A,G,T), RS1001887965 (16:366471 C>T), RS1002183000 (16:370728 G>C), RS1002526305 (16:368216 A>G), RS1002558680 (16:368074 T>C), RS1003341911 (16:371490 G>A), RS1003388015 (16:371253 C>G,T), RS1003442993 (16:367599 G>A), RS1003497797 (16:371731 A>G), RS1005478347 (16:366956 C>CCAA), RS1005589259 (16:366535 C>T), RS1005653603 (16:370409 C>T), RS1006035397 (16:370571 G>A,C)
Disease associations
OMIM: gene MIM:604853 | disease phenotypes: MIM:157900
GenCC curated gene-disease
Mondo (1): Mobius syndrome (MONDO:0008006)
Orphanet (1): Moebius syndrome (Orphanet:570)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_12 | Body mass index | 5.000000e-11 |
| GCST006288_170 | Heel bone mineral density | 5.000000e-11 |
| GCST006288_338 | Heel bone mineral density | 2.000000e-17 |
| GCST006288_444 | Heel bone mineral density | 1.000000e-25 |
| GCST010002_107 | Refractive error | 6.000000e-18 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0009270 | heel bone mineral density |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D020331 | Mobius Syndrome | C07.465.299.825; C10.292.319.825; C10.292.562.700.375.750; C11.590.436.400.750; C16.131.077.578; C16.614.595 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases expression, decreases expression | 2 |
| bisphenol F | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| deoxynivalenol | increases expression | 1 |
| nobiletin | decreases reaction, increases expression | 1 |
| sodium arsenate | increases expression, decreases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| nickel sulfate | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dinitrochlorobenzene | affects binding | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Methapyrilene | decreases methylation | 1 |
| Phenobarbital | affects expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03059420 | Not specified | RECRUITING | Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Mobius syndrome